Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALStandard

ESTRADIOL

ESTRADIOL

Standard Dose
0.05MG/DAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview ESTRADIOL is listed in Drugs@FDA under application 020167 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient ESTRADIOL Form and strength SYSTEM; TRANSDERMAL - 0.05MG/DAY Sponsor MYLAN PHARMS INC Submission history Latest submission status date: 2014-12-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESTRADIOL is listed in Drugs@FDA under application 020167 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient ESTRADIOL Form and strength SYSTEM; TRANSDERMAL - 0.05MG/DAY Sponsor MYLAN PHARMS INC Submission history Latest submission status date: 2014-12-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.